Bergal H, Kinoshita K, Wong W
bioRxiv. 2025; .
PMID: 40060606
PMC: 11888394.
DOI: 10.1101/2025.02.27.640408.
Kondo N, Mimori-Kiyosue Y, Tokuhiro K, Pezzotti G, Kinashi T
Nat Commun. 2025; 16(1):1343.
PMID: 39905041
PMC: 11794545.
DOI: 10.1038/s41467-025-56631-1.
Gad A, Morris J, Godret-Miertschin L, Montalvo M, Kerr S, Berger H
Sci Adv. 2025; 11(2):eadq8114.
PMID: 39792660
PMC: 11721525.
DOI: 10.1126/sciadv.adq8114.
Mastrogiovanni M, Donnadieu E, Pathak R, Di Bartolo V
Biology (Basel). 2024; 13(11).
PMID: 39596815
PMC: 11591779.
DOI: 10.3390/biology13110860.
Morales-Martinez M, Andon-Garcia D, Patino-Santiago K, Parga-Ortega J, Hernandez-Hernandez A, Aquino-Jarquin G
Sci Rep. 2024; 14(1):22219.
PMID: 39333573
PMC: 11436975.
DOI: 10.1038/s41598-024-73003-9.
Differential roles of kinetic on- and off-rates in T-cell receptor signal integration revealed with a modified Fab'-DNA ligand.
Wilhelm K, Vissa A, Groves J
Proc Natl Acad Sci U S A. 2024; 121(39):e2406680121.
PMID: 39298491
PMC: 11441509.
DOI: 10.1073/pnas.2406680121.
Ligand-induced segregation from large cell-surface phosphatases is a critical step in γδ TCR triggering.
Li F, Roy S, Niculcea J, Gould K, Adams E, Anton van der Merwe P
Cell Rep. 2024; 43(9):114761.
PMID: 39276348
PMC: 11452322.
DOI: 10.1016/j.celrep.2024.114761.
Ligand binding initiates single-molecule integrin conformational activation.
Li J, Jo M, Yan J, Hall T, Lee J, Lopez-Sanchez U
Cell. 2024; 187(12):2990-3005.e17.
PMID: 38772370
PMC: 11162317.
DOI: 10.1016/j.cell.2024.04.049.
Differential Roles of Kinetic On- and Off-Rates in T-Cell Receptor Signal Integration Revealed with a Modified Fab'-DNA Ligand.
Wilhelm K, Vissa A, Groves J
bioRxiv. 2024; .
PMID: 38617215
PMC: 11014569.
DOI: 10.1101/2024.04.01.587588.
LFA-1 nanoclusters integrate TCR stimulation strength to tune T-cell cytotoxic activity.
Lacouture C, Chaves B, Guipouy D, Houmadi R, Duplan-Eche V, Allart S
Nat Commun. 2024; 15(1):407.
PMID: 38195629
PMC: 10776856.
DOI: 10.1038/s41467-024-44688-3.
Mind the GAP: RASA2 and RASA3 GTPase-activating proteins as gatekeepers of T cell activation and adhesion.
Johansen K, Golec D, Okkenhaug K, Schwartzberg P
Trends Immunol. 2023; 44(11):917-931.
PMID: 37858490
PMC: 10621891.
DOI: 10.1016/j.it.2023.09.002.
T Cell Microvilli: Finger-Shaped External Structures Linked to the Fate of T Cells.
Kim H, Park J, Soh W, Kim N, Moon H, Lee J
Immune Netw. 2023; 23(1):e3.
PMID: 36911802
PMC: 9995986.
DOI: 10.4110/in.2023.23.e3.
Early T-bet promotes LFA1 upregulation required for CD8+ effector and memory T cell development.
Pritchard G, Phan A, Christian D, Blain T, Fang Q, Johnson J
J Exp Med. 2022; 220(2).
PMID: 36445307
PMC: 9712775.
DOI: 10.1084/jem.20191287.
Mesenchymal stem cells derived from adipose tissue accelerate the progression of colon cancer by inducing a MTCAF phenotype ICAM1/STAT3/AKT axis.
Xue C, Gao Y, Sun Z, Li X, Zhang M, Yang Y
Front Oncol. 2022; 12:837781.
PMID: 36016615
PMC: 9398219.
DOI: 10.3389/fonc.2022.837781.
LFA1 Activation: Insights from a Single-Molecule Approach.
Kondo N, Ueda Y, Kinashi T
Cells. 2022; 11(11).
PMID: 35681446
PMC: 9179313.
DOI: 10.3390/cells11111751.
Targeting protein-protein interaction for immunomodulation: A sunflower trypsin inhibitor analog peptidomimetic suppresses RA progression in CIA model.
Dahal A, Parajuli P, Singh S, Shrestha L, Sonju J, Shrestha P
J Pharmacol Sci. 2022; 149(3):124-138.
PMID: 35641025
PMC: 9208026.
DOI: 10.1016/j.jphs.2022.04.005.
Regulation of Dynamic Cell Adhesion by Integrin-Integrin Crosstalk.
Gahmberg C, Gronholm M, Madhavan S
Cells. 2022; 11(10).
PMID: 35626722
PMC: 9140058.
DOI: 10.3390/cells11101685.
Reduction of Cell Surface T-Cell Receptor by Non-Mitogenic CD3 Antibody to Mitigate Murine Lupus.
Morita M, Mizui M, Masuyama S, Tsokos G, Isaka Y
Front Immunol. 2022; 13:855812.
PMID: 35419004
PMC: 8995471.
DOI: 10.3389/fimmu.2022.855812.
The magnitude of LFA-1/ICAM-1 forces fine-tune TCR-triggered T cell activation.
Ma V, Hu Y, Kellner A, Brockman J, Velusamy A, Blanchard A
Sci Adv. 2022; 8(8):eabg4485.
PMID: 35213231
PMC: 8880789.
DOI: 10.1126/sciadv.abg4485.
Assessing Blood-Based Biomarkers to Define a Therapeutic Window for Natalizumab.
Granell-Geli J, Izquierdo-Gracia C, Selles-Rius A, Teniente-Serra A, Presas-Rodriguez S, Mansilla M
J Pers Med. 2021; 11(12).
PMID: 34945819
PMC: 8706232.
DOI: 10.3390/jpm11121347.